| Systemic lupus erythematosus |
1.67 |
4.66e-1 |
45/135 (33.33%) |
C7;FCGR3B;C3;...
|
| Tuberculosis |
1.62 |
4.32e-1 |
159/180 (88.33%) |
CASP10;CTSS;FCGR3B;...
|
| Fc gamma R-mediated phagocytosis |
1.58 |
4.40e-1 |
79/97 (81.44%) |
CDC42;PAK1;FCGR3B;...
|
| Pentose and glucuronate interconversions |
1.57 |
3.70e-1 |
17/34 (50%) |
UGT2B28;UGP2;GUSB;...
|
| Sphingolipid metabolism |
1.55 |
3.91e-1 |
32/49 (65.31%) |
DEGS1;GALC;PLPP2;...
|
| Regulation of lipolysis in adipocytes |
1.55 |
3.40e-1 |
52/55 (94.55%) |
PLIN1;INSR;PLAAT3;...
|
| Retinol metabolism |
1.51 |
4.11e-1 |
41/68 (60.29%) |
UGT2B28;DHRS3;ADH1B;...
|
| Carbohydrate digestion and absorption |
1.48 |
4.82e-1 |
37/47 (78.72%) |
PLCB1;ATP1A2;PRKCB;...
|
| Amoebiasis |
1.48 |
4.39e-1 |
99/102 (97.06%) |
COL4A5;ARG1;COL4A6;...
|
| Leishmaniasis |
1.48 |
4.04e-1 |
67/77 (87.01%) |
FCGR3B;CYBA;C3;...
|
| Tyrosine metabolism |
1.47 |
4.04e-1 |
30/36 (83.33%) |
AOC3;ADH1B;AOX1;...
|
| Non-alcoholic fatty liver disease |
1.46 |
3.89e-1 |
126/155 (81.29%) |
CDC42;ADIPOQ;INSR;...
|
| Apoptosis |
1.44 |
4.18e-1 |
126/168 (75%) |
CASP10;TNFSF10;CTSS;...
|
| Intestinal immune network for IgA production |
1.44 |
3.92e-1 |
38/48 (79.17%) |
HLA-DPB1;HLA-DQB1;IL6;...
|
| RIG-I-like receptor signaling pathway |
1.44 |
3.79e-1 |
64/70 (91.43%) |
CASP10;DDX58;CASP8;...
|
| Antigen processing and presentation |
1.42 |
4.02e-1 |
60/78 (76.92%) |
CTSS;LGMN;HSPA1A;...
|
| Ascorbate and aldarate metabolism |
1.42 |
3.97e-1 |
15/30 (50%) |
UGT2B28;GUSB;ALDH9A1;...
|
| Natural killer cell mediated cytotoxicity |
1.40 |
4.18e-1 |
99/131 (75.57%) |
TNFSF10;PAK1;FCGR3B;...
|
| Insulin signaling pathway |
1.40 |
4.18e-1 |
121/137 (88.32%) |
INSR;CRK;BAD;...
|
| Epithelial cell signaling in Helicobacter pylori infect... |
1.39 |
4.20e-1 |
62/70 (88.57%) |
CDC42;PAK1;CXCL1;...
|
| Focal adhesion |
1.36 |
4.87e-1 |
180/201 (89.55%) |
COL4A5;CDC42;PAK1;...
|
| Hepatitis B |
1.36 |
4.83e-1 |
151/162 (93.21%) |
CASP10;EGR3;BAD;...
|
| Protein processing in endoplasmic reticulum |
1.36 |
4.70e-1 |
127/171 (74.27%) |
SEL1L;DERL2;HSPA1A;...
|
| Tight junction |
1.35 |
4.61e-1 |
130/169 (76.92%) |
CDC42;CLDN8;HCLS1;...
|
| Bacterial invasion of epithelial cells |
1.35 |
4.51e-1 |
59/77 (76.62%) |
CDC42;HCLS1;CRK;...
|
| Viral myocarditis |
1.35 |
4.40e-1 |
53/60 (88.33%) |
BID;DMD;HLA-DPB1;...
|
| Herpes simplex virus 1 infection |
1.34 |
4.53e-1 |
165/498 (33.13%) |
BST2;BAD;BID;...
|
| Leukocyte transendothelial migration |
1.33 |
4.74e-1 |
90/114 (78.95%) |
CDC42;CLDN8;CYBA;...
|
| Pertussis |
1.32 |
5.06e-1 |
64/76 (84.21%) |
SERPING1;CALML5;GNAI1;...
|
| Gastric acid secretion |
1.31 |
5.06e-1 |
63/76 (82.89%) |
PLCB1;CALML5;GNAI1;...
|
| Bladder cancer |
-1.23 |
4.79e-1 |
40/41 (97.56%) |
E2F2;THBS1;FGFR3;...
|
| Fat digestion and absorption |
-1.23 |
4.88e-1 |
35/43 (81.4%) |
PNLIPRP2;APOA4;CLPS;...
|
| Th1 and Th2 cell differentiation |
-1.24 |
4.89e-1 |
80/92 (86.96%) |
JUN;NFATC1;CD3G;...
|
| Steroid biosynthesis |
-1.25 |
4.79e-1 |
19/20 (95%) |
NSDHL;EBP;CYP24A1;...
|
| RNA polymerase |
-1.26 |
4.74e-1 |
23/31 (74.19%) |
POLR3F;POLR3K;POLR3C;...
|
| Salivary secretion |
-1.26 |
4.70e-1 |
76/93 (81.72%) |
CST2;PRKCA;ATP1A1;...
|
| Maturity onset diabetes of the young |
-1.27 |
4.74e-1 |
21/26 (80.77%) |
HHEX;HNF4G;HNF1B;...
|
| Fructose and mannose metabolism |
-1.28 |
4.59e-1 |
30/33 (90.91%) |
FBP1;PMM1;HKDC1;...
|
| NF-kappa B signaling pathway |
-1.31 |
3.94e-1 |
90/104 (86.54%) |
ZAP70;MALT1;PLCG1;...
|
| Alanine, aspartate and glutamate metabolism |
-1.32 |
3.77e-1 |
27/37 (72.97%) |
CAD;ASL;GLS2;...
|
| Glyoxylate and dicarboxylate metabolism |
-1.32 |
3.88e-1 |
23/30 (76.67%) |
PGP;AMT;GRHPR;...
|
| PD-L1 expression and PD-1 checkpoint pathway in cancer |
-1.33 |
3.80e-1 |
79/89 (88.76%) |
JUN;NFATC1;PIK3CA;...
|
| Glucagon signaling pathway |
-1.33 |
3.96e-1 |
89/107 (83.18%) |
PPARA;PRKAG1;CPT1A;...
|
| Purine metabolism |
-1.34 |
3.91e-1 |
102/129 (79.07%) |
ADSL;PDE1A;NME3;...
|
| Butanoate metabolism |
-1.34 |
4.00e-1 |
23/28 (82.14%) |
ABAT;GAD1;HMGCS2;...
|
| Protein digestion and absorption |
-1.35 |
4.09e-1 |
78/103 (75.73%) |
XPNPEP2;CPA1;CELA3A;...
|
| Malaria |
-1.35 |
4.34e-1 |
44/50 (88%) |
KLRB1;CR1;GYPA;...
|
| Sulfur metabolism |
-1.35 |
4.50e-1 |
9/10 (90%) |
ETHE1;TST;MPST;...
|
| TGF-beta signaling pathway |
-1.36 |
4.53e-1 |
81/94 (86.17%) |
LTBP1;TGIF2;SMURF1;...
|
| Nicotinate and nicotinamide metabolism |
-1.38 |
4.45e-1 |
25/35 (71.43%) |
NNT;NMNAT2;NMRK1;...
|
| Other types of O-glycan biosynthesis |
-1.41 |
3.78e-1 |
29/47 (61.7%) |
POGLUT1;COLGALT2;POFUT1;...
|
| Pancreatic secretion |
-1.41 |
4.01e-1 |
87/102 (85.29%) |
SLC12A2;PLA2G2A;PLA2G2F;...
|
| Other glycan degradation |
-1.43 |
3.86e-1 |
13/18 (72.22%) |
MAN2B2;MAN2C1;ENGASE;...
|
| Primary immunodeficiency |
-1.44 |
3.94e-1 |
33/38 (86.84%) |
IGLL1;CD40LG;DCLRE1C;...
|
| Ribosome |
-1.44 |
4.39e-1 |
113/158 (71.52%) |
RPL4;MRPL17;MRPL35;...
|
| RNA degradation |
-1.48 |
3.61e-1 |
53/79 (67.09%) |
MTREX;PABPC1;EXOSC9;...
|
| Central carbon metabolism in cancer |
-1.51 |
3.19e-1 |
67/70 (95.71%) |
PGAM1;MET;PFKM;...
|
| Sulfur relay system |
-1.52 |
3.49e-1 |
5/8 (62.5%) |
TST;MPST;MOCS2;...
|
| Synthesis and degradation of ketone bodies |
-1.52 |
4.35e-1 |
9/10 (90%) |
HMGCS2;ACAT2
|
| Mucin type O-glycan biosynthesis |
-1.59 |
4.90e-1 |
20/36 (55.56%) |
GCNT3;ST6GALNAC4;GALNT7;...
|
